Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CAROLYN S HALL and ANTHONY LUCCI.
CAROLYN S HALL
Connection Strength
3.451
ANTHONY LUCCI
  1. Circulating Tumor Cells in Breast Cancer Patients. Crit Rev Oncog. 2016; 21(1-2):125-39.
    View in: PubMed
    Score: 0.563
  2. Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S552-8.
    View in: PubMed
    Score: 0.538
  3. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer. 2012 Jan 15; 118(2):342-8.
    View in: PubMed
    Score: 0.412
  4. How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers. Oncology (Williston Park). 2011 Jan; 25(1):47, 50.
    View in: PubMed
    Score: 0.398
  5. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010 Dec; 17(12):3252-8.
    View in: PubMed
    Score: 0.383
  6. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4265-4274.
    View in: PubMed
    Score: 0.199
  7. Circulating Tumor Cells in Breast Cancer. Recent Results Cancer Res. 2020; 215:127-145.
    View in: PubMed
    Score: 0.186
  8. Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2014 Sep; 147(2):325-33.
    View in: PubMed
    Score: 0.128
  9. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol. 2014 Sep; 2(5):845-850.
    View in: PubMed
    Score: 0.127
  10. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med. 2013 Apr; 2(2):226-33.
    View in: PubMed
    Score: 0.116
  11. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 2010 Jul 15; 116(14):3330-7.
    View in: PubMed
    Score: 0.096
  12. Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res. 2011 Jun 01; 168(1):e39-49.
    View in: PubMed
    Score: 0.094
  13. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells. J Surg Res. 2008 Jun 15; 147(2):240-6.
    View in: PubMed
    Score: 0.082
  14. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4615-4622.
    View in: PubMed
    Score: 0.050
  15. Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019 Jun 20; 11(6).
    View in: PubMed
    Score: 0.045
  16. Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clin Cancer Res. 2016 05 15; 22(10):2583-93.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.